Multiplexed immunofluorescence reveals potential PD-1/PD-L1 pathway vulnerabilities in craniopharyngiomaShannon Coy, Sandro Santagata, Rumana Rashid et al.|Neuro-Oncology|2018Cited by 113
A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1–associated pediatric low-grade glioma: a Neurofibromatosis Clinical Trials Consortium studyNicole J. Ullrich, Mark W. Kieran, David Viskochil et al.|Neuro-Oncology|2020Cited by 82
Helicobacter pylori, gastritis and non-ulcer dyspepsia in Ethiopian patients.E Tsega, Tsegahun Asfaw, Wondwoosen Gebre et al.|PubMed|1996Cited by 21
CRAN-11. MULTIPLEXED IMMUNOFLUORESCENCE REVEALS POTENTIAL PD-1/PD-L1 PATHWAY VULNERABILITIES IN CRANIOPHARYNGIOMAShannon Coy, Sandro Santagata, Rumana Rashid et al.|Neuro-Oncology|2018Cited by 2